Triple probe FISH approach for detecting EML4-ALK gene rearrangement in Chinese patients with NSCLC

被引:0
|
作者
Mao, Weimin
Han, Mark
Ling, Zhiqiang
Sun, Wenyong
Zhang, Gu
Dong, Hongshan
Zhang, Yingzi
机构
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[2] GeneDiagnost Inc, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21080
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Bilgin, Burak
    Sendur, Mehmet Ali Nahit
    Yucel, Sebnem
    Hizal, Mutlu
    Guner, Gurkan
    Akyurek, Nalan
    Erol, Cihan
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    Kilickap, Sadettin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
  • [42] EML4-ALK Fusion Detected by qRT-PCR Confers Similar Response to Crizotinib as Detected by FISH in Patients with Advanced NSCLC
    Ren, Shengxiang
    Wang, Yan
    Gao, Guanghui
    Li, Xuefei
    Zhao, Chao
    Su, Chunxia
    Chen, Xiaoxia
    He, Yayi
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S694 - S694
  • [43] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
    Burak Bilgin
    Mehmet Ali Nahit Şendur
    Şebnem Yücel
    Mutlu Hizal
    Gürkan Güner
    Nalan Akyürek
    Cihan Erol
    Muhammed Bülent Akıncı
    Didem Şener Dede
    Bülent Yalçın
    Sadettin Kılıçkap
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643
  • [44] Frequency of Concomitant EGFR, EML4-ALK or KRAS Alterations in NSCLC Patients and Correlation with Response to Treatment
    Ulivi, Paola
    Chiadini, Elisa
    Dazzi, Claudio
    Dubini, Alessandra
    Costantini, Matteo
    Medri, Laura
    Puccetti, Maurizio
    Capelli, Laura
    Calistri, Daniele
    Verlicchi, Alberto
    Gamboni, Alessandro
    Papi, Maximilian
    Mariotti, Marita
    De Luigi, Nicoletta
    Scarpi, Emanuela
    Bravaccini, Sara
    Turolla, Gian Michele
    Amadori, Dino
    Crino, Lucio
    Delmonte, Angelo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S297 - S297
  • [45] EGFR, EML4-ALK, ROS 1 and BRAF testing in Austrian patients with NSCLC: a multicentre study
    Holzer, Sophia
    Rumbold, Rosemarie
    Setinek, Ulrike
    Krenbek, Dagmar
    Mohn-Staudner, Andrea
    Kirchbacher, Klaus
    Dworan, Nina
    Arns, Britt-Madelaine
    Bundalo, Tatjana
    Patocka, Kurt
    Burghuber, Otto Chris
    Hochmair, Maximilian
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 769 - 769
  • [46] EGFR, EML4-ALK and ROS1 testing in Austrian patients with NSCLC: a multicenter study
    Hochmair, M. J.
    Holzer, S.
    Setinek, U.
    Mohn-Staudner, A.
    Kirchbacher, K.
    Dworan, N.
    Arns, B. M.
    Breyer, M-K
    Funk, G. C.
    Pirker, C.
    Patocka, K.
    Burghuber, O. C.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 (19-20) : 680 - 681
  • [47] EGFR, EML4-ALK, ROS 1 and BRAF Testing in Austrian Patients with NSCLC: A Multicenter Study
    Holzer, Sophia
    Hochmair, Maximilian
    Setinek, Ulrike
    Krenbek, Dagmar
    Fabikan, Hannah
    Rumbold, Rosemarie
    Mohn-Staudner, Andrea
    Kirchbacher, Klaus
    Arns, Madeleine
    Bundalo, Tatjana
    Patocka, Kurt
    Burghuber, Otto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S596 - S596
  • [48] Exosomal RNA Based Liquid Biopsy Detection of EML4-ALK in Plasma from NSCLC Patients
    Brinkmann, Kay
    Carbone, David P.
    Enderle, Daniel
    Koestler, Tina
    Bentink, Stefan
    Emenegger, Jennifer
    Spiel, Alexandra
    Mueller, Romy
    O'Neill, Vince
    Skog, Johan
    Noerholm, Mikkel
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S691 - S691
  • [49] NSCLC Patients with an Isolated 5′ Green Signal Pattern in ALK FISH Testing may be Positive for Complex EML4-ALK Rearrangement with 3′ Deletion and May Benefit from Crizotinib Targeted Therapy
    Sun, G.
    Montella, L.
    Woo, S.
    Kozon, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 713 - 714
  • [50] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283